Trial Profile
A Study to Evaluate the Long Term Efficacy and Safety of Entecavir in Patients with NUC-naive Chronic Hepatitis B in Real Life
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- 08 Dec 2015 New trial record